Federal Reserve Chairman Jerome Powell attends the House Financial Services Committee hearing on Capitol Hill in Washington, U.S., September 30, 2021. Al Drago | Reuters Expect more tough talk from the Federal Reserve, as it may consider winding down its bond program sooner than expected. Based on comments from a number of Fed officials, market
0 Comments
In this review, we cover trading on the Scottrade website. Visit Scottrade: https://tradersfly.com/go/scottrade/ For information on signing up to Scottrade please visit the resources page: https://tradersfly.com/resources/ #scottrade #tradingplatform #trading #onlinebroker #brokerreview Posted at: https://tradersfly.com/blog/scottrade-review-trading-on-the-website/ ? GET MY FREEBIES Freebies ? SUBMIT A VOICE QUESTION Question – Hungry for Returns ? START HERE: FOR NEW TRADERS
0 Comments
In this article TSLA AAPL Closely watched money manager Cathie Wood told CNBC on Wednesday that Apple could have owned the driverless vehicle market by purchasing Tesla when given the chance during the electric vehicle maker’s troubled Model 3 ramp-up. “We’ve been watching Apple very carefully for years now. Because what is an autonomous vehicle?
0 Comments
A Gap store in New York, August 2, 2020. Scott Mlyn | CNBC Check out the companies making headlines in midday trading. Gap, Nordstrom — Shares of Gap and Nordstrom plummeted after the companies reported disappointing quarterly results late Tuesday citing rising labor costs, inventory issues, shopping costs and factory closures as challenges. Gap shares dropped
0 Comments
It’s fascinating to witness Wall Street turning against telecommunications giant AT&T (NYSE:T) stock. The way they’re treating this iconic company, you’d think AT&T was headed toward zero. Source: Roman Tiraspolsky / Shutterstock.com Of course, that won’t happen anytime soon. Part of the problem is that the market has been rotating out of telecom stocks. This trend,
0 Comments
After months of consolidation, Bionano Genomics (NASDAQ:BNGO) is breaking down. BNGO stock has plummeted 30% since announcing earnings in early November. While the earnings report was decent, some legitimate concerns and a lack of news continue to weigh on shares. Source: Shutterstock / PopTika I’ll admit the genome analysis company is compelling, but investors should wait
0 Comments